These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36517170)

  • 1. Early rhythm-control therapy for atrial fibrillation in patients with a history of stroke: a subgroup analysis of the EAST-AFNET 4 trial.
    Jensen M; Suling A; Metzner A; Schnabel RB; Borof K; Goette A; Haeusler KG; Zapf A; Wegscheider K; Fabritz L; Diener HC; Thomalla G; Kirchhof P
    Lancet Neurol; 2023 Jan; 22(1):45-54. PubMed ID: 36517170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation.
    Kirchhof P; Camm AJ; Goette A; Brandes A; Eckardt L; Elvan A; Fetsch T; van Gelder IC; Haase D; Haegeli LM; Hamann F; Heidbüchel H; Hindricks G; Kautzner J; Kuck KH; Mont L; Ng GA; Rekosz J; Schoen N; Schotten U; Suling A; Taggeselle J; Themistoclakis S; Vettorazzi E; Vardas P; Wegscheider K; Willems S; Crijns HJGM; Breithardt G;
    N Engl J Med; 2020 Oct; 383(14):1305-1316. PubMed ID: 32865375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial.
    Willems S; Borof K; Brandes A; Breithardt G; Camm AJ; Crijns HJGM; Eckardt L; Gessler N; Goette A; Haegeli LM; Heidbuchel H; Kautzner J; Ng GA; Schnabel RB; Suling A; Szumowski L; Themistoclakis S; Vardas P; van Gelder IC; Wegscheider K; Kirchhof P
    Eur Heart J; 2022 Mar; 43(12):1219-1230. PubMed ID: 34447995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure.
    Rillig A; Magnussen C; Ozga AK; Suling A; Brandes A; Breithardt G; Camm AJ; Crijns HJGM; Eckardt L; Elvan A; Goette A; Gulizia M; Haegeli L; Heidbuchel H; Kuck KH; Ng A; Szumowski L; van Gelder I; Wegscheider K; Kirchhof P
    Circulation; 2021 Sep; 144(11):845-858. PubMed ID: 34328366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presenting Pattern of Atrial Fibrillation and Outcomes of Early Rhythm Control Therapy.
    Goette A; Borof K; Breithardt G; Camm AJ; Crijns HJGM; Kuck KH; Wegscheider K; Kirchhof P;
    J Am Coll Cardiol; 2022 Jul; 80(4):283-295. PubMed ID: 35863844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Rhythm Control in Patients With Atrial Fibrillation and High Comorbidity Burden.
    Rillig A; Borof K; Breithardt G; Camm AJ; Crijns HJGM; Goette A; Kuck KH; Metzner A; Vardas P; Vettorazzi E; Wegscheider K; Zapf A; Kirchhof P
    Circulation; 2022 Sep; 146(11):836-847. PubMed ID: 35968706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eligibility for early rhythm control in patients with atrial fibrillation in the UK Biobank.
    Kany S; Cardoso VR; Bravo L; Williams JA; Schnabel R; Fabritz L; Gkoutos GV; Kirchhof P
    Heart; 2022 Nov; 108(23):1873-1880. PubMed ID: 35835543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of early rhythm control vs. usual care in atrial fibrillation care: an analysis based on data from the EAST-AFNET 4 trial.
    Gottschalk S; Kany S; König HH; Crijns HJ; Vardas P; Camm AJ; Wegscheider K; Metzner A; Rillig A; Kirchhof P; Dams J
    Europace; 2023 May; 25(5):. PubMed ID: 36966734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of genetic risk and outcomes in patients with atrial fibrillation: interactions with early rhythm control in the EAST-AFNET4 trial.
    Kany S; Al-Taie C; Roselli C; Pirruccello JP; Borof K; Reinbold C; Suling A; Krause L; Reissmann B; Schnabel RB; Zeller T; Zapf A; Wegscheider K; Fabritz L; Ellinor PT; Kirchhof P
    Cardiovasc Res; 2023 Aug; 119(9):1799-1810. PubMed ID: 37264683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic monitoring for detection of atrial fibrillation in patients with acute ischaemic stroke (MonDAFIS): a randomised, open-label, multicentre study.
    Haeusler KG; Kirchhof P; Kunze C; Tütüncü S; Fiessler C; Malsch C; Olma MC; Jawad-Ul-Qamar M; Krämer M; Wachter R; Michalski D; Kraft A; Rizos T; Gröschel K; Thomalla G; Nabavi DG; Röther J; Laufs U; Veltkamp R; Heuschmann PU; Endres M;
    Lancet Neurol; 2021 Jun; 20(6):426-436. PubMed ID: 34022169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial.
    Kirchhof P; Breithardt G; Camm AJ; Crijns HJ; Kuck KH; Vardas P; Wegscheider K
    Am Heart J; 2013 Sep; 166(3):442-8. PubMed ID: 24016492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generalizability of the EAST-AFNET 4 Trial: Assessing Outcomes of Early Rhythm-Control Therapy in Patients With Atrial Fibrillation.
    Dickow J; Kirchhof P; Van Houten HK; Sangaralingham LR; Dinshaw LHW; Friedman PA; Packer DL; Noseworthy PA; Yao X
    J Am Heart Assoc; 2022 Jun; 11(11):e024214. PubMed ID: 35621202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of long-term sodium channel blocker therapy for early rhythm control: the EAST-AFNET 4 trial.
    Rillig A; Eckardt L; Borof K; Camm AJ; Crijns HJGM; Goette A; Breithardt G; Lemoine MD; Metzner A; Rottner L; Schotten U; Vettorazzi E; Wegscheider K; Zapf A; Heidbuchel H; Willems S; Fabritz L; Schnabel RB; Magnussen C; Kirchhof P
    Europace; 2024 Jun; 26(6):. PubMed ID: 38702961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Rhythm Control Therapy for Atrial Fibrillation in Low-Risk Patients : A Nationwide Propensity Score-Weighted Study.
    Kim D; Yang PS; You SC; Jang E; Yu HT; Kim TH; Pak HN; Lee MH; Lip GYH; Sung JH; Joung B
    Ann Intern Med; 2022 Oct; 175(10):1356-1365. PubMed ID: 36063552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Rhythm Control and the Risks of Ischemic Stroke, Heart Failure, Mortality, and Adverse Events When Performed Early (<3 Months): A Nationwide Cohort Study of Newly Diagnosed Patients with Atrial Fibrillation.
    Chao TF; Chan YH; Chiang CE; Tuan TC; Liao JN; Chen TJ; Lip GYH; Chen SA
    Thromb Haemost; 2022 Nov; 122(11):1899-1910. PubMed ID: 35322396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: the EAST-AFNET 4 trial.
    Eckardt L; Sehner S; Suling A; Borof K; Breithardt G; Crijns H; Goette A; Wegscheider K; Zapf A; Camm J; Metzner A; Kirchhof P
    Eur Heart J; 2022 Oct; 43(40):4127-4144. PubMed ID: 36036648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A support programme for secondary prevention in patients with transient ischaemic attack and minor stroke (INSPiRE-TMS): an open-label, randomised controlled trial.
    Ahmadi M; Laumeier I; Ihl T; Steinicke M; Ferse C; Endres M; Grau A; Hastrup S; Poppert H; Palm F; Schoene M; Seifert CL; Kandil FI; Weber JE; von Weitzel-Mudersbach P; Wimmer MLJ; Algra A; Amarenco P; Greving JP; Busse O; Köhler F; Marx P; Audebert HJ
    Lancet Neurol; 2020 Jan; 19(1):49-60. PubMed ID: 31708447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (Find-AF
    Wachter R; Gröschel K; Gelbrich G; Hamann GF; Kermer P; Liman J; Seegers J; Wasser K; Schulte A; Jürries F; Messerschmid A; Behnke N; Gröschel S; Uphaus T; Grings A; Ibis T; Klimpe S; Wagner-Heck M; Arnold M; Protsenko E; Heuschmann PU; Conen D; Weber-Krüger M;
    Lancet Neurol; 2017 Apr; 16(4):282-290. PubMed ID: 28187920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risks and Benefits of Early Rhythm Control in Patients With Acute Strokes and Atrial Fibrillation: A Multicenter, Prospective, Randomized Study (the RAFAS Trial).
    Park J; Shim J; Lee JM; Park JK; Heo J; Chang Y; Song TJ; Kim DH; Lee HA; Yu HT; Kim TH; Uhm JS; Kim YD; Nam HS; Joung B; Lee MH; Heo JH; Pak HN;
    J Am Heart Assoc; 2022 Feb; 11(3):e023391. PubMed ID: 35043663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale and design of AXAFA-AFNET 5: an investigator-initiated, randomized, open, blinded outcome assessment, multi-centre trial to comparing continuous apixaban to vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation.
    Di Biase L; Callans D; Hæusler KG; Hindricks G; Al-Khalidi H; Mont L; Cosedis Nielsen J; Piccini JP; Schotten U; Kirchhof P
    Europace; 2017 Jan; 19(1):132-138. PubMed ID: 28130378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.